| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/03/2008 | WO2008037418A1 Green tea medicinal extract, especially for use in the prophylaxis and treatment of diseases of the central nervous system or metabolic diseases, its use for producing a drug and method for producing the same |
| 04/03/2008 | WO2008037417A1 Green tea extract, especially for use as a functional food item, food supplement or corresponding ingredient, the use thereof and method for producing said green tea extract |
| 04/03/2008 | WO2008037222A1 A hypolipidemic composition and its use |
| 04/03/2008 | WO2008019143A3 Use of exendins and glp-i receptor agonists for altering lipoprotein particle size and subclass composition |
| 04/03/2008 | WO2008015563A3 Salts of rosuvastatin and processes for their preparation |
| 04/03/2008 | WO2007133778A3 Methods to restore glycemic control |
| 04/03/2008 | WO2007115973A3 Food products for hypophosphoric normo-, hyper- and hypoproteic diets, and their use for nutrition of subjects in need of a low phosphorus level diet |
| 04/03/2008 | WO2007100789A3 Gpat3 encodes a mammalian, microsomal acyl-coa:glycerol 3-phosphate acyltransferase |
| 04/03/2008 | WO2007100562A3 Use of dha and ara in the preparation of a composition for reducing triglyceride levels |
| 04/03/2008 | US20080081927 Crystal forms of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine |
| 04/03/2008 | US20080081840 High protein content combined wtih carbohydrates, fats and docosahexaenoic acid; satiation feel |
| 04/03/2008 | US20080081837 Use Of Furan Alkyl For Preparing An Antidiabetic Drug |
| 04/03/2008 | US20080081826 System for effecting weight loss |
| 04/03/2008 | US20080081825 5-((2,4-difluorophenyl) {[(1-methyl-4-piperidinyl)oxy]imino}methyl)-1-(2,6-dimethylphenyl)-2(1H)-pyridinone; p38 MAP kinase and tumor necrosis factor inhibitor; inflammatory cytokines or chemokine, respiratory diseases, cardiovascular diseases and bone diseases |
| 04/03/2008 | US20080081823 increase of the blood glucose level or decreasing the blood glucose level; enhancing insulin sensitivity or improving insulin resistance; antilipemic agents; use in foods, supplements, animal feeds; nontoxic |
| 04/03/2008 | US20080081820 SUBSTITUTED 8'-PYRI(MI)DINYL-DIHYDROSPIRO-[CYCLOALKYLAMINE]-PYRIMIDO[1,2-a]PYRIMIDIN-6-ONE DERIVATIVES |
| 04/03/2008 | US20080081819 1'-[(2S)-2-Hydroxy-2-phenylethyl]-8'-pyridin-4-yl-3',4'-dihydrospiro[cyclopropane-1,2'-pyrimido[1,2-a]pyrimidin]-6'(1'H)-one; glycogen synthase kinase-3 beta inhibitor; neurodegenerative disease, non-insulin dependent diabetes; inhibit amyloid precursor protein and tau protein hyperphosphorylation |
| 04/03/2008 | US20080081813 Lipid Lowering Biphenylcarboxamides |
| 04/03/2008 | US20080081812 and inverse agonist; 2-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-5-(pyridin-4-yl)-1,3,4-oxadiazole; obesity and obesity-related metabolic disorders |
| 04/03/2008 | US20080081800 2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs |
| 04/03/2008 | US20080081799 2-Methylene-(20S,25S)-19,27-Dinor-(22E)-Vitamin D Analogs |
| 04/03/2008 | US20080081786 Cytokine protein family |
| 04/03/2008 | US20080081781 Methods and compositions for the treatment of metabolic syndrome |
| 04/03/2008 | US20080081084 Methods and compositions for improving cardiovascular risk factors and metabolic risk factors that cause syndrome x |
| 04/03/2008 | US20080081083 Methods and compositions for improving cardiovascular risk factors and metabolic risk factors that cause syndrome x |
| 04/03/2008 | US20080081068 Modified release formulations of a bupropion salt |
| 04/03/2008 | DE202007017517U1 Fluvastatinnatrium Fluvastatin sodium |
| 04/03/2008 | CA2774197A1 Drugs and uses to modulate inflammation, metabolic disorders and other conditions |
| 04/03/2008 | CA2770486A1 Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer |
| 04/03/2008 | CA2700431A1 Nutrient sensor |
| 04/03/2008 | CA2664358A1 Diarylketimine derivative |
| 04/03/2008 | CA2662992A1 2-methylene-(20r,25s)-19,27-dinor-(22e)-vitamin d analogs |
| 04/03/2008 | CA2662864A1 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs |
| 04/02/2008 | EP1905830A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/02/2008 | EP1905782A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 04/02/2008 | EP1905771A2 Quinuclidine derivatives and their use |
| 04/02/2008 | EP1905769A1 Heterocycle-substituted benzimidazole derivative |
| 04/02/2008 | EP1905763A1 N-acylic aminoacid derivatives. method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents |
| 04/02/2008 | EP1905759A1 N-[1-(3-amino-4-phenyl-butyryl)-4-hydroxy-pyrrolidin-2-ylmethyl}-propionamide and related compounds as dpp-iv inhibitors for the treatment oftype 2 diabetes mellitus |
| 04/02/2008 | EP1905757A1 Derivatives of Venlafaxine and methods of preparing and using the same |
| 04/02/2008 | EP1905450A1 Pharmaceutical composition containing ppar gamma agonist |
| 04/02/2008 | EP1905438A2 Hypoglycemic agent |
| 04/02/2008 | EP1905431A1 Pravastatin pharmaceutical formulations and methods of their use |
| 04/02/2008 | EP1904466A1 Dicycloalkyl urea glucokinase activators |
| 04/02/2008 | EP1904442A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 04/02/2008 | EP1904082A2 Method for determining the concentration of the adipocytic form of the fatty acid binding protein (a-fabp, fabp4, p2) |
| 04/02/2008 | EP1904058A2 Combination of a dpp-iv inhibitor and a cannabinoid cb1 receptor antagonist |
| 04/02/2008 | EP1904055A1 Composition for inhibiting acyl-coa:cholesterol acyltransferase |
| 04/02/2008 | EP1903895A2 Calcium-peptide component |
| 04/02/2008 | EP1793817A4 Methods of treating a disorder |
| 04/02/2008 | EP1682664A4 Methods for the production of apolipoproteins in transgenic plants |
| 04/02/2008 | EP1638556B1 2-aminobenzothiazoles as cb1 receptor inverse agonists |
| 04/02/2008 | EP1397153B1 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 04/02/2008 | EP1392331B1 Use of colesevelam or sevelamer hydrogen chloride for lowering serum glucose |
| 04/02/2008 | EP0964692B1 Use of glp-1 or analogs in treatment of myocardial infarction |
| 04/02/2008 | CN101155796A Imidazole derivatives |
| 04/02/2008 | CN101155790A 1,2,4-triazine derivatives, preparation and use thereof in human therapy |
| 04/02/2008 | CN101155788A Crystal of 4(3h)-quinazolinone derivative |
| 04/02/2008 | CN101155781A Pyridine-3-carboxamide derivatives as cb1 inverse agonists |
| 04/02/2008 | CN101155587A Modulators of muscarinic receptors |
| 04/02/2008 | CN101155586A Oral dosage form comprising rosiglitazone |
| 04/02/2008 | CN101155585A Oral dosage form comprising rosiglitazone |
| 04/02/2008 | CN101153262A Health edible calcium-zinc vinegar |
| 04/02/2008 | CN101153053A Bone-peptide, producing method, pharmaceutical composition and uses thereof |
| 04/02/2008 | CN101153039A 13, 13a- dihydro berberine derivant, pharmaceutical composition and uses of the same |
| 04/02/2008 | CN101152466A Strengthening and iron compensating black rice medicinal granules, and method for preparing the same |
| 04/02/2008 | CN101152395A Chinese medicine for treating diabetes |
| 04/02/2008 | CN101152341A Health care tea of ganoderma lucidum medicinal herbs |
| 04/02/2008 | CN101152318A Traditional Chinese medicine with cooperativeness therapy |
| 04/02/2008 | CN101152285A Pharmaceutical composition of snakegourd fruit and whitethorn leaf |
| 04/02/2008 | CN101152246A Pharmaceutical composition for cardiovascular and cerebrovascular diseases and method for preparing the same |
| 04/02/2008 | CN101152236A Weight-reducing health-care food |
| 04/02/2008 | CN101152233A Pharmaceutical composition of snakegourd fruit and folium ginkgo |
| 04/02/2008 | CN101152198A Drug administration preparations of nasal cavity for treating diabetes |
| 04/02/2008 | CN101152188A Vitamin D* solid dispersion peridium patch and method for preparing the same |
| 04/02/2008 | CN101152187A Eplerenone pharmaceutical composition |
| 04/02/2008 | CN101152179A Application of isoniazide as histone deacetylase inhibitors |
| 04/02/2008 | CN101152160A Oral pharmaceutical formulation containing ibandronate |
| 04/02/2008 | CN100378118C Pharmaceutical compositions having appetite suppressant activity |
| 04/02/2008 | CN100378108C Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/02/2008 | CN100378100C Pyrazolo(4,3-d)pyrimidine derivatives |
| 04/02/2008 | CN100378074C 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 04/02/2008 | CN100377734C Extract of plant dendrobii caulis and preparing process and use thereof |
| 04/02/2008 | CN100377719C Yeast cell walls for the treatment or prevention of hyperglycemia or for the stabilisation of glycemia |
| 04/02/2008 | CN100377711C Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 04/02/2008 | CN100377705C Calcium hydrophenyl sulfonate capsule and its preparation process |
| 04/01/2008 | US7351860 Method and device for producing formic acid formates and use of said formates |
| 04/01/2008 | US7351839 Process for the preparation of 1,2,3,4,8,9,10, 10a-octahydro-7bH-cyclopenta[b][1,4]diazepino-[6,7,1-hi]indole derivatives |
| 04/01/2008 | US7351736 Therapeutic compositions (II) |
| 04/01/2008 | US7351730 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 04/01/2008 | US7351728 peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis |
| 04/01/2008 | US7351725 For therapy of immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection |
| 04/01/2008 | US7351719 Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
| 04/01/2008 | US7351707 Spiroazacyclic compounds as monoamine receptor modulators |
| 04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
| 04/01/2008 | US7351702 Caspase inhibitors and uses thereof |
| 04/01/2008 | US7351695 Topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms; seizures, obesity, neuropathic pain, affective disorders, tobacco cessation, chronic fatigue syndrome, drug addiction; highly soluble, bioavailability |
| 04/01/2008 | US7351551 Adipocyte differentiation-associated gene and protein |
| 04/01/2008 | US7351410 Glycogen storage disease type II treatment comprising human acid glucosidase, mannitol and sucrose in aqueous solution |
| 04/01/2008 | CA2371896C Method of increasing the content of flavonoids and phenolic substances in plants |